ArticleCancer cell2010

Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate.

Bin Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.